2023
DOI: 10.1136/bmjmed-2022-000229
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of first dose of covid-19 vaccine versus no vaccination on symptoms of patients with long covid: target trial emulation based on ComPaRe e-cohort

Abstract: ObjectiveTo evaluate the effect of covid-19 vaccination on the severity of symptoms in patients with long covid.DesignTarget trial emulation based on ComPaRe e-cohort.Data sourceComPaRe long covid cohort, a nationwide e-cohort (ie, a cohort where recruitment and follow-up are performed online) of patients with long covid, in France.MethodsAdult patients (aged ≥18 years) enrolled in the ComPaRe cohort before 1 May 2021 were included in the study if they reported a confirmed or suspected SARS-CoV-2 infection, sy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
21
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 54 publications
(30 citation statements)
references
References 25 publications
(23 reference statements)
1
21
0
Order By: Relevance
“…On the other hand, it is also possible that COVID-19 was less functionally significant during Wave 2, and patients did not require extensive rehabilitation and care services. Vaccination likely contributed to the relatively milder presentations in Wave 2 [22], [23]. However, this data was not routinely available for analysis in this study.…”
Section: Discussionmentioning
confidence: 93%
“…On the other hand, it is also possible that COVID-19 was less functionally significant during Wave 2, and patients did not require extensive rehabilitation and care services. Vaccination likely contributed to the relatively milder presentations in Wave 2 [22], [23]. However, this data was not routinely available for analysis in this study.…”
Section: Discussionmentioning
confidence: 93%
“…This would not only have knock-on benefits for other children, thereby further reducing risk of infection and adverse events, but would also break transmission chains which could result in older or otherwise vulnerable individuals contracting COVID-19, for whom there is a much higher risk of severe outcomes [ 55 ]. Furthermore, there are additional indirect benefits to the vaccinated individuals that have not been considered, including shorter or less severe Long Covid if it occurs [ 56 ] and reduced school-related absenteeism [ 57 ] as a consequence of reduced infection and Long Covid rates, that can have longer term health-related and socio-economic impacts [ 58 ].…”
Section: Discussionmentioning
confidence: 99%
“…Among seven studies that compared vaccinated and unvaccinated individuals with established PCC [44][45][46][47][48][49][50], three studies addressed the main outcome of PCC resolution following one dose, two of which did not demonstrate an association [46,49] and the third reported double the remission rate among vaccinated individuals [45] (Table 2). Three studies compared self-reported outcome data pre-and post-vaccination, all of which found beneficial outcomes after the first dose [42,51,52].…”
Section: (Q3) Changes In Pcc Following Vaccination Among Individuals ...mentioning
confidence: 99%